Human CTGF/CCN2/HCS24 ORF/cDNA clone-Adenovirus plasmid (NM_001901.2)
Cat. No.: pGMAD000129
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human CTGF/CCN2/HCS24 adenoviral expression plasmid for CTGF adenovirus packaging, CTGF adenovirus.
Our GM-Adenovirus vector is optimized with the GMVC-modified Adeasy adenovirus packaging system. Find more about the GMVC-modified adenovirus packaging system.
Go to
CTGF/CCN2 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
Catalog ID | pGMAD000129 |
Gene Name | CTGF |
Accession Number | NM_001901.2 |
Gene ID | 1490 |
Species | Human |
Product Type | Adenovirus plasmid (overexpression) |
Insert Length | 1050 bp |
Gene Alias | CCN2,HCS24,IGFBP8,NOV2 |
Fluorescent Reporter | GFP |
Mammalian Cell Selection | Null |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | EF1 |
Resistance | Amplicin |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Target information
Target ID | GM-T50444 |
Target Name | CTGF |
Gene ID | 1490, 14219, 714520, 64032, 101094598, 476202, 281103, 100073098 |
Gene Symbol and Synonyms | CCN2,CTGF,CTGRP,fisp-12,Fisp12,HCS24,IGFBP8,NOV2 |
Uniprot Accession | P29279 |
Uniprot Entry Name | CCN2_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target, INN Index, Cytokine Target |
Disease | Ovary Cancer, Chronic Kidney Disease, Type 1 diabetes mellitus with diabetic nephropathy, gastric cancer, Complications of kidney transplant |
Gene Ensembl | ENSG00000118523 |
Target Classification | Not Available |
The protein encoded by this gene is a mitogen that is secreted by vascular endothelial cells. The encoded protein plays a role in chondrocyte proliferation and differentiation, cell adhesion in many cell types, and is related to platelet-derived growth factor. Certain polymorphisms in this gene have been linked with a higher incidence of systemic sclerosis. [provided by RefSeq, Nov 2009]
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.